Milestone Pharmaceuticals Inc.   Report issue

For profit Phase 3
Founded: Montreal Canada (2003)

Organization Overview

First Clinical Trial
2015
NCT02296190
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Milestone Pharmaceuticals Inc.